Chemomab Therapeutics Ltd. (CMMB)
Market Open
15 Jun, 14:47
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
1. 58
-0.07
-4.2424%
$
10.16M Market Cap
- P/E Ratio
- Div Yield
41,564 Volume
- Eps
$ 1.65
Previous Close Investors:
Want to track CMMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
CMMB Earnings Reports FAQ
What is the earnings per share (EPS) for CMMB?
EPS data for CMMB is currently not available, as Chemomab Therapeutics Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Chemomab Therapeutics Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Chemomab Therapeutics Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Chemomab Therapeutics Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for CMMB at this time, as Chemomab Therapeutics Ltd has no recent EPS data to calculate it.
